Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (211-220 of 927) with videos related to

Pageof 93
Sort By:
Current Medical Research and Opinion|September 28, 2022
Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the NetherlandsEdith M Heintjes, Anastassia Anastassopoulou, Josephina Kuiper, et al.
Genes|March 29, 2023
Feasibility of Community Pharmacist-Initiated and Point-of-Care <i>CYP2C19</i> Genotype-Guided De-Escalation of Oral P2Y12 InhibitorsAmar D Levens, Melina C den Haan, J Wouter Jukema, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 29, 2025
Bridging Therapy and Risk of Bleeding and Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients: A Quasi-Experimental StudyEleonora Camilleri, Robin P W Roovers, Eva Janssen, et al.
Atherosclerosis|January 21, 2021
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?Dan Atar, J Wouter Jukema, Bart Molemans, et al.
Atherosclerosis. Supplements|February 16, 2021
Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath toolAlessandro Sionis, Alberico L Catapano, Gaetano M De Ferrari, et al.
The American Journal of Cardiology|March 12, 2019
Comparison of Diagnostic Performance of Quantitative Flow Ratio in Patients With Versus Without Diabetes MellitusJeff M Smit, Mohammed El Mahdiui, Alexander R van Rosendael, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 9, 2026
Reply to Letter: "Bridging in Left Ventricular Assist Device Patients"Eleonora Camilleri, Robin P W Roovers, Eva Janssen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 20, 2025
Symptomatic early coronary graft failure in bypass surgery patients: incidence, predictors and clinical impactMartijn J H van Oort, Ibtihal Al Amri, Arend de Weger, et al.
Circulation|March 26, 2003
Value of magnetic resonance imaging for the noninvasive detection of stenosis in coronary artery bypass grafts and recipient coronary arteriesSusan E Langerak, Hubert W Vliegen, J Wouter Jukema, et al.
Clinical Pharmacology and Therapeutics|April 20, 2018
A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular DiseaseMathijs C Bodde, Paul Welsh, Sandrin C Bergheanu, et al.
Pageof 93

Showing results (211-220 of 927) with videos related to

Sort By:
Pageof 93
Current Medical Research and Opinion|September 28, 2022
Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the NetherlandsEdith M Heintjes, Anastassia Anastassopoulou, Josephina Kuiper, et al.
Genes|March 29, 2023
Feasibility of Community Pharmacist-Initiated and Point-of-Care <i>CYP2C19</i> Genotype-Guided De-Escalation of Oral P2Y12 InhibitorsAmar D Levens, Melina C den Haan, J Wouter Jukema, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 29, 2025
Bridging Therapy and Risk of Bleeding and Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients: A Quasi-Experimental StudyEleonora Camilleri, Robin P W Roovers, Eva Janssen, et al.
Atherosclerosis|January 21, 2021
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?Dan Atar, J Wouter Jukema, Bart Molemans, et al.
Atherosclerosis. Supplements|February 16, 2021
Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath toolAlessandro Sionis, Alberico L Catapano, Gaetano M De Ferrari, et al.
The American Journal of Cardiology|March 12, 2019
Comparison of Diagnostic Performance of Quantitative Flow Ratio in Patients With Versus Without Diabetes MellitusJeff M Smit, Mohammed El Mahdiui, Alexander R van Rosendael, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 9, 2026
Reply to Letter: "Bridging in Left Ventricular Assist Device Patients"Eleonora Camilleri, Robin P W Roovers, Eva Janssen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 20, 2025
Symptomatic early coronary graft failure in bypass surgery patients: incidence, predictors and clinical impactMartijn J H van Oort, Ibtihal Al Amri, Arend de Weger, et al.
Circulation|March 26, 2003
Value of magnetic resonance imaging for the noninvasive detection of stenosis in coronary artery bypass grafts and recipient coronary arteriesSusan E Langerak, Hubert W Vliegen, J Wouter Jukema, et al.
Clinical Pharmacology and Therapeutics|April 20, 2018
A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular DiseaseMathijs C Bodde, Paul Welsh, Sandrin C Bergheanu, et al.
Pageof 93